Fruquintinib Plus TAS-102 Demonstrates Efficacy and Acceptable Toxicity in Pretreated mCRC Updated phase 2 data revealed fruquintinib plus TAS-102 could offer survival benefits in pretreated metastatic colorectal cancer.

Fruquintinib Plus TAS-102 Demonstrates Efficacy and Acceptable Toxicity in Pretreated mCRC @ascocancer.bsky.social #GI24 #crcsm #oncology
www.onclive.com/view/fruquin...

First-Line Nivolumab/Chemo Generates Long-Term Survival Benefits in Gastric/GEJ/Esophageal Cancer Frontline nivolumab plus chemotherapy elicited clinically meaningful long-term survival benefits vs chemotherapy alone in advanced gastric/GEJ cancer.

First-Line Nivolumab/Chemo Generates Long-Term Survival Benefits in Gastric/GEJ/Esophageal Cancer @mskcancercenter.bsky.social @ascocancer.bsky.social #GI24 #esocsm #oncology
www.onclive.com/view/first-l...

2300 exhibitors stretching beyond the horizon of 100000 m² hosting 1500 #CNC machines and more tools to invent, mill, bend, weld, bolt and transform materials into something smart and useful. Global Industrie Paris #GI24 — a creative counterpoint to a global trend of destruction.

No trip to San Francisco would be complete without a stop at the village tea house. Their stuffed eggplant and tofu with shrimp and their pork sheng Jian bao dumplings are a religious experience.
#GI24

Bow ties are back for #BowTieFriday. Its a true miracle on Day 2 of #GI24 in stunning #SF . Looking forward to another day filled with learning and connecting with old friends and new. @djweiner.bsky.social @engagetheo.bsky.social @docwithbowtie.bsky.social CanSky MedSky hapc hpm